Showing results (1-10 of 224) with videos related to
Sort By:
Pageof 23
Biotechnology Healthcare|April 6, 2012
Setting the Bar Higher For Off-Label Use of Biologics: Off-label use of biologics is common as physicians strive for optimal treatment. Patients want whatever works. Drug makers want expanded labeling, but payers chafe at the lack of efficacy data. Is there an answer to this conundrum?Ed SilvermanBiotechnology Healthcare|April 6, 2012
5 things employers want to know about biologicsWilliam AtkinsonBiotechnology Healthcare|April 6, 2012
A Renewed Emphasis on Therapeutic Angiogenesis Research for CADJack JacobsBiotechnology Healthcare|April 6, 2012
Lower cost and faster product approval through proper software design controlsKevin Stevens, Anthony JohnsonBiotechnology Healthcare|April 6, 2012
MRSA: The Private-Sector ResponseVirginia Jackson, David B NashBiotechnology Healthcare|April 6, 2012
Creating a pathway over the regulatory chasm: a fresh startEd SilvermanBiotechnology Healthcare|April 6, 2012
Making the case for biotechnology Reinsurance (BIO-RE)Bruce PyensonBiotechnology Healthcare|April 6, 2012
Building a value-based approach to biologic drugsJanice L Clarke, Alexis Skoufalos, David B Nash, et al.Pageof 23